NeuroPace Inc - NPCE Net earnings per share for the last four quarters

NeuroPace Inc (NPCE) - corporate logo

The price action history for NeuroPace, Inc. (NPCE) on the GURU.Markets platform demonstrates a profit level of 26.00. NeuroPace, Inc. (NPCE) dominates the epilepsy treatment segment by implementing intelligent RNS systems to suppress seizures. The company has modernized production through AI-driven robotization of assembly and quality control processes. Financial success is based on the sale of high-tech neurostimulators and subsequent global patient service support.

neuropace.com (NPCE) Net earnings per share for the last 12 months: for the period 02/11/2024 - 11/14/2026

NeuroPace Inc - analytical breakdowns and key metrics (NPCE)

- stock price and consensus target price:
Price NeuroPace|NPCE - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization NeuroPace Corp|NPCE - Enterprise Value
- book value of equity indicators:
Accounting Value per Share NeuroPace|NPCE - Company Net Assets|Market Value to Book Value neuropace.com|NPCE - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio NeuroPace, Inc.|NPCE - Long-Term Debt to Capital|Current Liabilities to Capital NeuroPace, Inc.|NPCE - Company Aggregate Debts|Debt to Book Value Ratio NeuroPace Corp|NPCE - Company Long-Term Debts|Short-Term Debt Volume NeuroPace|Quick Liquidity Indicator neuropace.com
- earnings and market multiples details:
NPCE - Net Profit|Projected Future Earnings NeuroPace, Inc.|NPCE - Price to Earnings Ratio|Future Price to Earnings NeuroPace, Inc.|NPCE - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation NeuroPace Corp|NPCE - Operating profit EBITDA|Net earnings per one share for the last twelve months NeuroPace|NPCE - Earnings per share for the last twelve months|Net earnings per share growth for the trailing year neuropace.com|NPCE - Net earnings per share growth this year|Earnings growth forecast for next year NeuroPace, Inc.
- sales volume and revenue information:
NPCE - Revenue and Sales Volume|Company Future Sales NeuroPace Inc|NPCE - Price-to-Revenue Ratio|Future Price to Revenue NeuroPace Medical
Fundamental company valuation:NeuroPace, NPCE
Manufactured product of NeuroPace

Year-over-year (YoY) EPS growth (TTM) measures the dynamics of net income per share, eliminating quarterly gaps to reveal the true earnings trend. Investors utilize the historical EPS YoY TTM delta to determine if an asset is overvalued during extreme growth peaks. For NeuroPace, Inc. (NPCE), this metric reflects the scaling efficiency of neurostimulator implantations. The stability of this metric confirms control over marketing expenses while maintaining a safe level of liquidity.

Competitor analysis for NeuroPace, Inc.

Dexcom - Earnings per share for the last four quarters|PEN: Net earnings per share (EPS TTM)|NOVT - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HAE|Net earnings per share for the last 12 months Inspire Medical Systems, Inc. (INSP)|Net earnings per share for the last 12 months PRCT (PROCEPT BioRobotics Corporation)|CNMD (CONMED Corp) - Earnings per share for the trailing year|Earnings per share for the last twelve months Pulse Medical PLSE|INMD - Net earnings per share for the last 12 months|Picard Medical - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Surmodics, Inc.|SENS: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TCMD|SNWV (SANUWAVE Health Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Outset Medical Corp|Net earnings per share (EPS TTM) ELMD|Net earnings per share for the last 12 months LENSAR, Inc. LNSR|Net earnings per share (EPS TTM) RCEL (avitamedical.com)|Net earnings per share (EPS TTM) Profound Medical Corp. PROF|BDMD - Earnings per share for the last twelve months|EDAP: Earnings per share for the last twelve months|APYX (Bovie Medical) - Net earnings per share for the last 12 months|IceCure Medical Ltd. - Earnings per share for the trailing year|LUNG (Pulmonx Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months telabio.com TELA|Earnings per share for the last twelve months CytoSorbents Corporation (CTSO)|Sensus Healthcare, Inc. (SRTS) - Net earnings per share for the trailing year|Zynex Corp - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) electroCore Medical ECOR|Vicarious Surgical Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Inspira Technologies IINN|SeaStar Medical Holding Corp. (ICU) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months IRIX (IRIDEX Corp.)|Earnings per share for the last twelve months ibs.inc|Net earnings per share for the last 12 months Beyond Air, Inc. (XAIR)|Net earnings per share (EPS TTM) PFSA|SSKN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months GlucoTrack GCTK|NAOV: Earnings per share for the last 12 months|VERO: Net earnings per share for the last 12 months|nuwellis.com - Earnings per share for the last four quarters|AEMD: Net earnings per share (EPS TTM)|TransEnterix (ASXC) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months AVGR|biosig.com (BSGM) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CUTR (Cutera, Inc)|Net earnings per share for the last 12 months Know Labs KNW|Earnings per share for the last twelve months Inari Medical NARI|Earnings per share for the trailing year NVRO|ReShape Lifesciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SILK (Silk Road Medical Inc)